Stock BNGO BIONANO GENOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Market Closed - Nasdaq
Other stock markets
 21:00:00 02/05/2024 BST 		5-day change 1st Jan Change
0.9493 USD -0.96% Intraday chart for Bionano Genomics, Inc. +25.07% -49.77%
04-17 Bionano Genomics, Hangzhou Diagens Biotechnology to Commercialize Cytogenetic Workflow for Reproductive Health MT
04-17 Bionano Genomics, Inc. and Hangzhou Diagens Biotechnology Co., Ltd. Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis That Combines OGM and Artificial Intelligence CI

Evolution of the average Target Price on Bionano Genomics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

35829512c425b9dc6b1031a82.-M1MlR5vfb1DR5BQojk9ESUkYOjiJPRo08tCe68KBZ4.vYQn_WpeLPs7BPkYxV1RJl1CK6mJT7kdjJslEMdtSKuXiR7fWipEi3Am2Q~5490e46428ba355293e11687cef7281a

Analyst Recommendations on Bionano Genomics, Inc.

Scotiabank Trims Price Target on Bionano Genomics to $6 From $7, Maintains Sector Outperform Rating MT
Maxim Group Adjusts Bionano Genomics Price Target to $6 From $30, Maintains Buy Rating MT
EF Hutton Initiates Bionano Genomics at Buy With $1.75 Price Target MT
BTIG Adjusts Price Target on Bionano Genomics to $2 From $3, Maintains Buy Rating MT
Oppenheimer Adjusts Bionano Genomics' Price Target to $9 From $12, Maintains Outperform Rating MT
Scotiabank Initiates Bionano Genomics at Sector Outperform With $4 Price Target MT
BTIG Assumes Bionano Genomics at Buy With $3.50 Price Target MT
Oppenheimer Adjusts Bionano Genomics Price Target to $12 From $14, Maintains Outperform Rating MT
BTIG Adjusts Bionano Genomics' Price Target to $7 From $10, Reiterates Buy Rating MT
Maxim Group Adjusts Bionano Genomics Price Target to $6 From $12, Maintains Buy Rating MT
BIONANO GENOMICS : BTIG Starts Bionano Genomics at Buy With $10 Price Target MT
BIONANO GENOMICS : Oppenheimer Adjusts Bionano Genomics PT to $14 From $15, Maintains Outperform Rating MT
BIONANO GENOMICS : Oppenheimer Adjusts Bionano Genomics' PT to $15 From $1.50, Citing Balance Sheet Expansion, Potential of $100 Genome; Outperform Rating Kept MT
BIONANO GENOMICS : Roth Capital Downgrades Bionano Genomics to Neutral From Buy; Price Target is $0.75 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.9585 USD
Average target price
6.667 USD
Spread / Average Target
+595.53%
High Price Target
11 USD
Spread / Highest target
+1,047.63%
Low Price Target
3 USD
Spread / Lowest Target
+212.99%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Bionano Genomics, Inc.

Scotiabank
Maxim
EF Hutton
BTIG
Oppenheimer

Ratings for Bionano Genomics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BNGO Stock
  4. Consensus Bionano Genomics, Inc.